The Department of Medical Oncology & Therapeutics at City of Hope’s National Medical Center in Duarte, California, comprises a multidisciplinary team of physicians, nurse practitioners, scientists and other health professionals. Together, they are dedicated to the diagnosis, treatment and research of tumors in patients to ensure optimal outcomes across a broad spectrum of diagnoses. The department has dedicated faculty for both its inpatient service and outpatient clinics, which are organized around cancer types. The staff also works closely with City of Hope’s surgery, radiation oncology and supportive care medicine departments to provide coordinated, comprehensive cancer care to patients and caregivers.
Why Choose City of Hope
The Department of Medical Oncology & Therapeutics Research has some of the finest and highly specialized medical oncologists anywhere. Many are cited as "America’s Top Doctors" and are world renowned. More importantly, our staff have excellent communication skills and that crucial quality — empathy. Combined with our extensive portfolio of clinical trials and continual medical progress, this means our patients will get the most advanced and compassionate care available, which gives them the best opportunity to lead longer and more fulfilling lives.
Medical Oncology Leadership
Ravi Salgia M.D., Ph.D., is the Arthur & Rosalie Kaplan Chair in Medical Oncology at City of Hope and an expert in the study and treatment of lung cancer, mesothelioma, thoracic and thymic malignancies and bronchial carcinoids.
Joanne Mortimer, M.D., Associate Director for Cancer Research Training and Education Coordination, Comprehensive Cancer Center and is the Baum Family Professor in Women’s Cancers.
Medical Oncology Research
The Department of Medical Oncology & Therapeutics Research collaborates with City of Hope's comprehensive cancer center's Developmental Cancer Therapeutics Program to develop next-generation cancer therapies that are more effective and less toxic to the patient. Our multidisciplinary program includes basic, translational and clinical research and fosters collaborations among scientists and clinicians. This synergistic effort aims to spark novel ideas that become new laboratory discoveries, which can transform into promising treatments for cancer patients with fewer or no other options. City of Hope's clinical trials study many of these therapies, which are open to our patients who meet eligibility criteria.
Kate and Robert Henderson Colloquium on Phenotypic Plasticity, Cancer and Evolution
Our Department of Medical Oncology & Therapeutics Research hosts the annual Kate and Robert Henderson Colloquium on Phenotypic Plasticity, Cancer & Evolution. The academic meeting is organized by City of Hope’s Ravi Salgia, M.D., Ph.D., and Prakash Kulkarni, Ph.D.
Education for Health Science Professionals
The Department of Medical Oncology and Therapeutics Research offers multiple education opportunities for health and science professionals:
